Literature DB >> 17223080

Bipartite nuclear localization signal of matrin 3 is essential for vertebrate cells.

Shoji Hisada-Ishii1, Mizuki Ebihara, Nao Kobayashi, Yasuo Kitagawa.   

Abstract

Matrin 3, a nuclear matrix protein has potential (1) to withhold promiscuously edited RNAs within the nucleus in cooperation with p54(nrb) and PSF, (2) to mediate NMDA-induced neuronal death, and (3) to modulate promoter activity of genes proximal to matrix/scaffold attachment region (MAR/SAR). We identified a bipartite nuclear localization signal (NLS) of chicken matrin 3 (cmatr3) at residues 583-602. By expressing green fluorescent protein (GFP) fused to the NLS mutant in chicken DT40 cells, we showed an essential role of the NLS for cell proliferation. Furthermore, we showed that both clusters of basic amino acids and a linker of the bipartite NLS were essential and sufficient for the nuclear import of GFP. Exogenous cmatr3 rescued the HeLa cells where human matrin 3 was suppressed by RNA interference, but cmatr3 containing deletions at either of the basic amino acid clusters or the linker could not.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17223080     DOI: 10.1016/j.bbrc.2006.12.191

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Heterogeneity of Matrin 3 in the developing and aging murine central nervous system.

Authors:  Sruti Rayaprolu; Simon D'Alton; Keith Crosby; Christina Moloney; John Howard; Colin Duffy; Mariela Cabrera; Zoe Siemienski; Abigail R Hernandez; Carolina Gallego-Iradi; David R Borchelt; Jada Lewis
Journal:  J Comp Neurol       Date:  2016-06-02       Impact factor: 3.215

2.  The alphaherpesvirus US3/ORF66 protein kinases direct phosphorylation of the nuclear matrix protein matrin 3.

Authors:  Angela Erazo; Michael B Yee; Bruce W Banfield; Paul R Kinchington
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

3.  p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation.

Authors:  Jia Yang Lu; Marion B Sewer
Journal:  Mol Cell Biol       Date:  2015-01-20       Impact factor: 4.272

4.  Identifying functional neighborhoods within the cell nucleus: proximity analysis of early S-phase replicating chromatin domains to sites of transcription, RNA polymerase II, HP1gamma, matrin 3 and SAF-A.

Authors:  Kishore S Malyavantham; Sambit Bhattacharya; Marcos Barbeitos; Lopamudra Mukherjee; Jinhui Xu; Frank O Fackelmayer; Ronald Berezney
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

5.  Nucleolar protein trafficking in response to HIV-1 Tat: rewiring the nucleolus.

Authors:  Mohamed Ali Jarboui; Carlo Bidoia; Elena Woods; Barbara Roe; Kieran Wynne; Giuliano Elia; William W Hall; Virginie W Gautier
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

6.  Matrin 3 is a co-factor for HIV-1 Rev in regulating post-transcriptional viral gene expression.

Authors:  Venkat S R K Yedavalli; Kuan-Teh Jeang
Journal:  Retrovirology       Date:  2011-07-20       Impact factor: 4.602

7.  Matrin 3 and HIV Rev regulation of mRNA.

Authors:  Andrew I Dayton
Journal:  Retrovirology       Date:  2011-07-20       Impact factor: 4.602

8.  Characterization of the HIV-1 RNA associated proteome identifies Matrin 3 as a nuclear cofactor of Rev function.

Authors:  Anna Kula; Jessica Guerra; Anna Knezevich; Danijela Kleva; Michael P Myers; Alessandro Marcello
Journal:  Retrovirology       Date:  2011-07-20       Impact factor: 4.602

9.  Matrin 3 binds and stabilizes mRNA.

Authors:  Maayan Salton; Ran Elkon; Tatiana Borodina; Aleksey Davydov; Marie-Laure Yaspo; Eran Halperin; Yosef Shiloh
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

10.  Nuclear matrix protein Matrin3 regulates alternative splicing and forms overlapping regulatory networks with PTB.

Authors:  Miguel B Coelho; Jan Attig; Nicolás Bellora; Julian König; Martina Hallegger; Melis Kayikci; Eduardo Eyras; Jernej Ule; Christopher W J Smith
Journal:  EMBO J       Date:  2015-01-19       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.